243 related articles for article (PubMed ID: 3159825)
1. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Sachs DH
J Exp Med; 1985 Jul; 162(1):231-44. PubMed ID: 3159825
[TBL] [Abstract][Full Text] [Related]
2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
3. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
Ildstad ST; Wren SM; Oh E; Hronakes ML
Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
[TBL] [Abstract][Full Text] [Related]
4. Multiple mixed chimeras: reconstitution of lethally irradiated mice with syngeneic plus allogeneic bone marrow from multiple strains.
Chester CH; Sykes M; Sachs DH
Res Immunol; 1989; 140(5-6):503-16. PubMed ID: 2675227
[TBL] [Abstract][Full Text] [Related]
5. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
Levite M; Reisner Y
Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
[TBL] [Abstract][Full Text] [Related]
6. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
Sharabi Y; Abraham VS; Sykes M; Sachs DH
Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10 + F344 rat----B10).
Ildstad ST; Wren SM; Sharrow SO; Stephany D; Sachs DH
J Exp Med; 1984 Dec; 160(6):1820-35. PubMed ID: 6239902
[TBL] [Abstract][Full Text] [Related]
8. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn).
Ildstad ST; Bluestone JA; Sachs DH
J Exp Med; 1986 May; 163(5):1343-8. PubMed ID: 2939173
[TBL] [Abstract][Full Text] [Related]
9. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
10. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
Khan A; Tomita Y; Sykes M
Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
[TBL] [Abstract][Full Text] [Related]
11. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
Markus PM; Selvaggi G; Cai X; Fung JJ; Starzl TE
Cell Transplant; 1993; 2(4):345-53. PubMed ID: 8162277
[TBL] [Abstract][Full Text] [Related]
12. Mixed xenogeneic chimeras (rat + mouse to mouse). Evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens.
Ildstad ST; Boggs SS; Vecchini F; Wren SM; Hronakes ML; Johnson PC; Van den Brink MR
Transplantation; 1992 Apr; 53(4):815-22. PubMed ID: 1566347
[TBL] [Abstract][Full Text] [Related]
13. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
[TBL] [Abstract][Full Text] [Related]
14. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
15. Clonal deletion: a mechanism of tolerance in mixed bone marrow chimeras.
Yu JC; Webster M; Fox IJ
J Surg Res; 1990 Jun; 48(6):517-22. PubMed ID: 2141885
[TBL] [Abstract][Full Text] [Related]
16. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
Wren SM; Hronakes ML; Ildstad ST
Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
[TBL] [Abstract][Full Text] [Related]
17. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
Koch U; Korngold R
Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cells, but not CD8+ T cells, mediate the breaking of tolerance in mixed allogeneic chimeras (B10 + B10.BR-->B10).
Wren SM; Hronakes ML; Ildstad ST
Transplantation; 1993 Jun; 55(6):1382-9. PubMed ID: 8100092
[TBL] [Abstract][Full Text] [Related]
19. Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras.
Rayfield LS; Brent L
Transplantation; 1983 Aug; 36(2):183-9. PubMed ID: 6349042
[TBL] [Abstract][Full Text] [Related]
20. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
Kanamoto A; Maki T
J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
